Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial

Manar Matar, Raanan Shamir, Dan Turner, Efrat Broide, Batia Weiss, Oren Ledder, Anat Guz-Mark, Firas Rinawi, Shlomi Cohen, Chani Topf-Olivestone, Ron Shaoul, Baruch Yerushalmi, Shomron Ben-Horin, Amit Assa*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology